Over the years of working as therapists, we have come to deeply respect traditional therapy. It is powerful, meaningful, and has helped so many people. At the same time, research over the past two decades has begun to explain something many clinicians noticed long ago: for some people, talking alone does not always reach the deeper layers of their emotional world. The science of psilocybin helps explain why, and what becomes possible when the medicine is paired with real therapeutic support.
What happens in the brain
Psilocybin works primarily on the brain’s serotonin system. Within the experience, brain regions that normally operate separately begin communicating in new ways, while the default mode network, the circuitry associated with our habitual sense of self and repetitive self-critical thinking, becomes quieter.
So much suffering lives in loops: the same worry, the same self-judgment, the same story about who we are, traveling well-worn neural pathways. When those pathways soften, people often gain a kind of spaciousness; they can see their lives, their pain, and their patterns from somewhere new.
Research also points to increased neuroplasticity in the days and weeks after a session, a window in which the brain is more open to forming new connections. This is one reason integration sits at the heart of our protocol: the weeks after the journey are when new ways of thinking and feeling can take root.
What the clinical research shows
The modern research era began at institutions like Johns Hopkins, NYU, and Imperial College London, and the findings have been consistent enough that the FDA designated psilocybin therapy a “breakthrough therapy” for depression.
Across studies, one or two guided psilocybin sessions, embedded in preparation and integration, have produced meaningful and durable reductions in depression and anxiety, including for people whose depression had resisted other treatments. Research with people facing serious illness found profound easing of end-of-life distress. Early studies on alcohol use showed significant reductions in drinking. The New York Times recently covered emerging work with former NFL players exploring psilocybin for the lasting effects of head injuries, work in which Numia was featured.
A consistent thread runs through all of it: the medicine was never given alone. Every strong result came from medicine plus preparation, skilled support, and integration. The relationship carries the science.
Why the body is part of the story
Trauma is known to be stored in the body. Sometimes we believe we can resolve everything with the prefrontal cortex, with reason, but some experiences settled into us before words, and they need more than words to move. This is the experiential side of the research: psilocybin seems to allow the ego to soften enough that what the body has been holding can finally surface, be felt, and be released, safely and with support.
This is why we describe our approach as a place where science meets care and tenderness. For us, the neuroscience and the warmth have always belonged together.
What the science cannot promise
We want to be honest here, because honesty is part of care. Psilocybin is not a magic pill. You do not simply have the journey and become a different person. What the research supports, and what we see in our work, is that the experience can open a door; walking through it is the work of integration, done gently, over time, in connection with people who know your story.
Indigenous cultures have worked with psilocybin for centuries, long before the modern research era, and we feel so honored to offer it to the Western world with that lineage in mind, truly appreciated rather than appropriated.
If the research resonates
If you are curious whether this approach fits your story, we would love to talk. Our facilitators have guided over 300 legal journeys here in Denver, Colorado, and every one of them began with a simple, free conversation.
This article summarizes published research for educational purposes and does not replace medical advice.
